Show simple item record

dc.contributor.authorJordan, S
dc.contributor.authorWilson, L
dc.contributor.authorNagle, C
dc.contributor.authorGreen, Adèle C
dc.contributor.authorOlsen, C
dc.contributor.authorBain, C
dc.contributor.authorPandeya, N
dc.contributor.authorWhiteman, D
dc.contributor.authorWebb, P
dc.date.accessioned2015-11-23T12:12:46Zen
dc.date.available2015-11-23T12:12:46Zen
dc.date.issued2015-10en
dc.identifier.citationCancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy. 2015, 39 (5):434-40 Aust N Z J Public Healthen
dc.identifier.issn1753-6405en
dc.identifier.pmid26437728en
dc.identifier.doi10.1111/1753-6405.12451en
dc.identifier.urihttp://hdl.handle.net/10541/582513en
dc.description.abstractTo estimate the proportion and number of cancers occurring in Australia in 2010 attributable to menopausal hormone therapy (MHT) use.
dc.language.isoenen
dc.rightsArchived with thanks to Australian and New Zealand journal of public healthen
dc.titleCancers in Australia in 2010 attributable to and prevented by the use of menopausal hormone therapy.en
dc.typeArticleen
dc.contributor.departmentQIMR Berghofer Medical Research Institute, Queenslanden
dc.identifier.journalAustralian and New Zealand Journal of Public Healthen
html.description.abstractTo estimate the proportion and number of cancers occurring in Australia in 2010 attributable to menopausal hormone therapy (MHT) use.


This item appears in the following Collection(s)

Show simple item record